News

GSK seeks FDA nod for expanded use of RSV vaccine in adults
(Reuters) -British drugmaker GSK said on Monday it had submitted an application to the U.S. Food and Drug Administration to ...
Zacks.com on MSN23h
FDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger Adults
FDA accepts GSK's filing to extend Arexvy's RSV vaccine use to high-risk adults under 50, with a decision due in 2026.
Medical Dialogues4h
GSK application for expanded RSV vaccine Arexvy use for adults 18-49 accepted for review by USFDA
London: GSK plc has announced that the US Food and Drug Administration (FDA) has accepted for review an application to extend ...
Devdiscourse16h
Health Sector Buzz: Mergers, Drugs, and CEO Shake-ups
Recent health news highlights various developments, including Trump's spending bill impacting insurance costs, a major acquisition in the bioscience sector, and GSK's efforts to expand RSV vaccine ...
Fierce Pharma23h
Regulatory tracker: FDA accepts GSK expansion filing for RSV vaccine Arexvy
Welcome to Fierce Pharma's regulatory tracker for the second half of 2025. | In this tracker, Fierce Pharma is recording the ...
Fierce Pharma21h
Humana kicks off virtual brain health challenge ahead of National Senior Games
It may not be an Olympic year, but Humana is still firing up some competition this summer. | It may not be an Olympic year, ...
Stocktwits on MSN23h
AstraZeneca Stock Rises As Experimental Drug Lowers Blood Pressure In Late-Stage Study, Retail’s Yet To React
AstraZeneca (AZN) on Monday said that its investigational drug Baxdrostat reduced systolic blood pressure (SBP) compared with ...
ViiV expands licence to allow generic HIV treatment production for low-income countries
ViiV Healthcare, the HIV-focused joint venture majority owned by GSK , said on Monday it has expanded its licensing deal with ...